{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T01:11:07Z","timestamp":1770340267121,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007467","name":"School of Medicine, Keio University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007467","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["19790981"],"award-info":[{"award-number":["19790981"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.bbrc.2011.05.149","type":"journal-article","created":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T00:16:01Z","timestamp":1307924161000},"page":"328-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lovastatin and valproic acid additively attenuate cell invasion in ACC-MESO-1 cells"],"prefix":"10.1016","volume":"410","author":[{"given":"Yoshikane","family":"Yamauchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yotaro","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Fukutomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Serizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Wakui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Nomori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2011.05.149_b0005","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/JTO.0b013e3181834f66","article-title":"Recent advances in the treatment of malignant pleural mesothelioma","volume":"3","author":"Ramalingam","year":"2008","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbrc.2011.05.149_b0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2007.11.036","article-title":"Statins in tumor suppression","volume":"260","author":"Sassano","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2011.05.149_b0015","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1158\/0008-5472.516.65.2","article-title":"Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux","volume":"65","author":"Riganti","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2011.05.149_b0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ijc.21832","article-title":"Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma","volume":"119","author":"Riganti","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2011.05.149_b0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/med.20027","article-title":"Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies","volume":"25","author":"Blaheta","year":"2005","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbrc.2011.05.149_b0030","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1158\/1078-0432.CCR-08-1579","article-title":"Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma","volume":"15","author":"Vandermeers","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2011.05.149_b0035","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bbrc.2004.01.104","article-title":"Statins inhibit osteoblast migration by inhibiting Rac-Akt signaling","volume":"315","author":"Fukuyama","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2011.05.149_b0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrd2221","article-title":"Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets","volume":"6","author":"Konstantinopoulos","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2011.05.149_b0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/med.20162","article-title":"Statins can modulate effectiveness of antitumor therapeutic modalities","volume":"30","author":"Jakobisiak","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbrc.2011.05.149_b0050","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","author":"Chateauvieux","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.bbrc.2011.05.149_b0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8722-3-5","article-title":"Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents","volume":"3","author":"Tan","year":"2010","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2011.05.149_b0060","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1158\/1078-0432.CCR-07-1595","article-title":"The roles of therapy-induced autophagy and necrosis in cancer treatment","volume":"13","author":"Amaravadi","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2011.05.149_b0065","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1158\/1055-9965.EPI-07-2917","article-title":"Diet, autophagy, and cancer: a review","volume":"17","author":"Singletary","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.bbrc.2011.05.149_b0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drup.2007.05.001","article-title":"Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy","volume":"10","author":"Moretti","year":"2007","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbrc.2011.05.149_b0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ccr.2006.06.001","article-title":"Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis","volume":"10","author":"Degenhardt","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2011.05.149_b0080","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrc2254","article-title":"Role of autophagy in cancer","volume":"7","author":"Mathew","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2011.05.149_b0085","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1158\/0008-5472.CAN-10-1626","article-title":"Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2011.05.149_b0090","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1158\/0008-5472.CAN-07-6161","article-title":"Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma","volume":"68","author":"Montero","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2011.05.149_b0095","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ejca.2008.02.043","article-title":"Blocking on the CXCR4\/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells","volume":"44","author":"Hashimoto","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2011.05.149_b0100","first-page":"941","article-title":"Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells","volume":"2","author":"Collisson","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2011.05.149_b0105","doi-asserted-by":"crossref","first-page":"30549","DOI":"10.1074\/jbc.M801436200","article-title":"Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion","volume":"283","author":"Fromigue","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.05.149_b0110","first-page":"217","article-title":"Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho","volume":"29","author":"Kusama","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2011.05.149_b0115","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrc1751","article-title":"Statins and cancer prevention","volume":"5","author":"Demierre","year":"2005","journal-title":"Nat. Rev. Cancer"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11009338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11009338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T10:55:13Z","timestamp":1757760913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X11009338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0006291X11009338"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2011.05.149","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lovastatin and valproic acid additively attenuate cell invasion in ACC-MESO-1 cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2011.05.149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}